TABLE 1.
Disease model | Phytochemical | Dosage | Experimental model | Pathobiology | Alteration in molecular markers in response to treatment | References |
---|---|---|---|---|---|---|
DN | Berberine | 300 mg/kg/d, 8 w | db/db diabetic mice | Mesangial matrix accumulation | ↓TG, ↓ACR, ↓FBG, ↓FFA, ↓Drp1 | Qin et al. (2019) |
200, 300 mg/kg/d, 8 w | db/db mice model | Lipid accumulation | ↓FFA, ↓TG | Qin et al. (2020) | ||
Curcumin | 100 mg/kg, 12 w | Streptozotocin (STZ)-injected rats | Fibrosis, inflammation, oxidative stress, mitochondrial dysfunction | ↓Collagen I/III, ↓TGF-β1, ↓NF-κB, ↓ROS, ↓MDA ↑GSH↑, ↑MnSOD, ↓cytochrome-C, ↓caspase-3, ↑Bcl-2↑, ↑Nrf-2, ↓p66Shc | ALTamimi et al. (2021) | |
Polydatin | 100 mg/kg, 8 w | KKAy mice | Mitochondrial dysfunction | ↓Drp1 | Ni et al. (2017) | |
Resveratrol | 30 mg/kg/d, 12 w | STZ-injected CD-1 mouse | Oxidative stress, apoptosis, mitochondrial dysfunction | ↑MnSOD, ↓MDA, ↓caspase 3 ↑SIRT1, ↑PGC-1α, ↑Nrf-1↑, ↑TFAM | Zhang et al. (2019) | |
Salidroside | 50, 100 mg/kg/d, 10 w | High-fat diet (HFD)/STZ-induced diabetic rats | Extracellular matrix (ECM) deposition, mitochondrial dysfunction | ↓collagen I, ↓FN, ↓α-SMA ↑SIRT1, ↑PGC-1α | Xue et al. (2019) | |
Obstructed nephropathy | Resveratrol | 12.5 or 25 mg/kg, 14 d | UUO-operated C57BL/6 mice | Fibrosis | ↓Collagen, ↓TGF-β/Smad, ↓FN, ↓α-SMA, SIRT1↑ | Liu et al. (2019) |
Aged kidney | Resveratrol | 40 mg/kg, 6 m | 18-month-old C57BL/6 mice | ECM accumulation, Apoptosis, Oxidative stress, mitochondrial dysfunction | ↓Col IV, ↓TGF-β1, ↑COX IV, ↑BCL-2, ↓Bax, ↑Nrf-2, ↑HO-1, ↑NQO-1, ↓ROS, ↑SOD, ↑SOD2, ↑SIRT1, ↑AMPK, ↑PGC-1α | Kim et al. (2018) |
Sepsis-induced AKI | Curcumin | 4 mg/kg, 1, 6, 12 and 24 h | Sepsis-induced AKI mice model | Inflammation, Oxidative stress | ↓IL-6, ↓ TNF-α ↓ROS, ↓MDA, ↑GSH, ↑SOD | Wang et al. (2021a) |
Polydatin | 30 mg/kg, 6, 12, 18 h | Rats with caecal ligation and puncture (CLP)-induced sepsis | Mitochondrial dysfunction, inflammation | ↑Mt membrane potential, ↑Mt-ATP levels ↓IL-6, ↓LPO | Gao et al. (2015) | |
30 mg/kg, 12 h | C57BL/6 mice with CLP-induced sepsis | Mitochondrial dysfunction, inflammation, apoptosis | ↓KIM-1, ↓NLRP3, ↓IL-6, ↓TNF-α, ↓IL-1β, ↓caspase-1, ↓Bax, ↓caspase-3 ↑ SIRT1, ↑Bcl-1 | Gao et al. (2020) | ||
Resveratrol | 0.3 ml; 50 mg/kg, 30 min | Rats with CLP-induced sepsis | Mitochondrial dysfunction | ↑SIRT1/3, ↑ATP, ↓cytochrome-C, ↑SOD2 | Xu et al. (2016) | |
Ischemia-reperfusion-induced AKI | Berberine | 20 and 40 mg/kg, 4 w | Renal ischemia/reperfusion (RIR)-induced Wistar rats | Oxidative stress | ↑SOD, ↑GSH, ↓MDA | Kaur et al. (2016) |
Mitochondrial dysfunction apoptosis | ↓KIM-1 | |||||
Inflammation | ↑Bcl-2, ↓caspase-3, ↓Bax | |||||
↓TNF-α | ||||||
Drug-induced AKI | Berberine | 10, 20, and 40 mg/kg; p.o., 7 d | Gentamycin–induced nephrotoxicity Sprague-Dawley rats | Oxidative stress, inflammation, apoptosis, mitochondrial dysfunction | ↓MDA, ↑SOD, ↑GSH | Adil et al. (2016) |
↓NF-κB | ||||||
↑Bcl-2 | ||||||
↑mt complex (I – IV), ↓NO, ↓KIM-1 | ||||||
Celastrol | 1, 2 mg/kg/d | Cisplatin-induced C57BL/6 mice | Oxidative stress, apoptosis, inflammation, mitochondrial dysfunction | ↓MDA | Yu et al. (2018) | |
↓Bax, ↑Bcl-2 | ||||||
↓IL-1β, ↓IL-6, ↓TNF-α, ↓ NF-κB p65 | ||||||
↓KIM -1, ↓NGAL | ||||||
Curcumin | 200 mg/kg/d, 3 d | Cisplatin-induced male Wister rats | mitochondrial dysfunction and dynamics | ↑SIRT3, ↑mt complex I, ↑OXPHOS | Ortega-Domínguez et al. (2017) | |
↓Fis1 | ||||||
↑OPA1, ↑MFN1 | ||||||
Chemical-induced AKI | Curcumin | 400 mg/kg, 5 d | Maleate-induced Wistar rats | Oxidative stress | ↓MDA, ↓ROS, ↑GSSG, ↑GSH | Molina-Jijón et al. (2016) |
Mitochondrial fragmentation | ↓Drp1, ↓Fis1 | |||||
400 mg/kg, 10 d | Chromium-induced Wistar rats | Oxidative stress | ↑CAT, ↑GR, ↑GPx, ↑SOD, ↑GSH, ↑GST | Molina-Jijón et al. (2011) | ||
Mitochondrial dysfunction | ↑mt complex (I – IV) | |||||
Resveratrol | 400 mg/kg, 90 d | Cadmium (Cd)-induced white chickens | Oxidative stress, mitochondrial dysfunction | ↑T-SOD, ↑Cu-Zn SOD, ↑CAT, ↑GST, ↑GSH-Px, ↓MDA, ↑Nrf-2 | Zhang et al. (2020) | |
↑SIRT3, ↑SIRT1, ↑PGC-1α, ↑Nrf-1, ↑TFAM | ||||||
400 mg/kg, 14 d | Aldosterone-induced C57BL/6J mice | Mitochondrial dysfunction | ↑PGC-1α, ↑TFAM, ↑SIRT-3 | Yuan et al. (2012) | ||
Other AKI-related diseases | Curcumin | 60 mg/kg/day, 7 d | Nephrectomy-induced Wistar rats | Oxidative stress, mitochondrial dysfunction | ↑CAT, ↑SOD, ↑GR, ↑GPx, ↑GST, ↑Nrf-2 | Ortega-Domínguez et al. (2017) |
↓Drp1, ↓Fis1, ↑mt complex I/V | ||||||
Resveratrol | 30 mg/kg, 1 h | Hemorrhagic shock-induced Evans rats | Oxidative stress, mitochondrial dysfunction | ↑SOD2, ↑CAT, ↑Nrf-2, ↓ROS ↓NGAL, ↓LP, ↓NADH, ↑SIRT1, ↑PGC1-α | Wang et al. (2015) |
ATP, adenosine triphosphate; AMPK, AMP-activated protein kinase; ACR, microalbumin-to-creatinine ratios; BCL-2, B-cell lymphoma 2; CAT, catalase; Col IV, Collagen IV; Cr, Chromium; Cd, cadmium; COX IV, Cytochrome Oxidase IV; Drp1, dynamin-related protein 1; ECM, Extracellular matrix; ERRAα, Estrogen-related receptor alpha; FBG, fasting blood glucose; FAO, fatty acid oxidation; FN, fibronectin; FFA, free fatty acids; Fis1, mitochondrial fission protein 1; GSSG, glutathione disulfide; GPx, glutathione peroxidase; GSH, glutathione; HO-1, Heme oxygenase-1; ICAM-1, intercellular adhesion molecule-1; IL-6, interleukin 6; IL-1β, interleukin 1 β; KIM-1, kidney injury molecule-1; Mid51 and Mid49, mitochondrial dynamics proteins of 51 and 49 kDa; MMP, mitochondrial membrane potential; mtDNA, mitochondrial DNA; MFF, mitochondrial fission protein; MnSOD, manganese superoxide dismutase; MMP-9, matrix metalloproteinase-9; MDA, malondialdehyde; NGAL, neutrophil gelatinase associated lipocalin; NQO-1, Quinone Oxidoreductase 1; NADH, nicotinamide adenine dinucleotide plus hydrogen; Nrf-1 and Nrf-2, nuclear respiratory factors 1 and 2; NF-κB, nuclear factor-kappa B; OXPHOS, oxidative phosphorylation; PPAR, peroxisome proliferator-activated receptor; PA, palmitic acid; PGC-1α, peroxisome proliferator-activated receptor-γ co-activator 1α; RIR, renal ischemia reperfusion; ROS, reactive oxygen species; STZ, streptozotocin; SIRT1, silent mating type information regulation 2 homolog 1; SOD1 and SOD2, superoxide dismutase 1 and 2; TBARS, thiobarbituric acid reactive substances; TFAM, transcription factor A; TG, triglyceride; TNF-α, tumor necrosis factor α; TGF-β1, transforming growth factor- β-1; UUO, unilateral ureteral obstruction; α-SMA, α-smooth muscle actin.